gptkbp:instance_of
|
gptkb:healthcare_organization
|
gptkbp:bfsLayer
|
5
|
gptkbp:bfsParent
|
gptkb:Lynch_syndrome
|
gptkbp:affects
|
adrenal glands
|
gptkbp:age
|
adults
|
gptkbp:associated_with
|
adrenaline
cortisol
aldosterone
|
gptkbp:clinical_trial
|
gptkb:vaccine
ongoing research
targeted therapy
|
gptkbp:end_of_life
|
varies by type
5-year survival rate
|
gptkbp:gender
|
more common in women
|
gptkbp:genetic_diversity
|
gptkb:Beckwith-Wiedemann_syndrome
gptkb:Multiple_Endocrine_Neoplasia_type_1
gptkb:Li-Fraumeni_syndrome
|
https://www.w3.org/2000/01/rdf-schema#label
|
adrenal cancer
|
gptkbp:is_involved_in
|
available for families
available for patients
|
gptkbp:is_organized_by
|
gptkb:healthcare_organization
Adrenal Cancer Foundation
|
gptkbp:is_popular_in
|
rare
|
gptkbp:number_of_stages
|
stage I
stage IV
stage II
stage III
|
gptkbp:public_awareness
|
Adrenal Cancer Awareness Month
|
gptkbp:research_focus
|
biomarkers
new drug development
genetic profiling
|
gptkbp:risk_factor
|
family history
genetic mutations
|
gptkbp:screenings
|
not routinely screened
|
gptkbp:social_responsibility
|
gptkb:MRI
CT scan
biopsy
varies by stage
|
gptkbp:symptoms
|
anxiety
fatigue
nausea
weight loss
abdominal pain
high blood pressure
sweating
|
gptkbp:treatment
|
gptkb:hospital
clinical trials
radiation therapy
chemotherapy
hormone therapy
|
gptkbp:type
|
gptkb:pheochromocytoma
adrenocortical carcinoma
primary adrenal cancer
|